Loss of expression of the DRR 1 gene at chromosomal segment 3p21.1 in renal cell carcinoma

Consistent deletion of DNA sequences in chromosomal band 3p21 observed in a variety of human tumors suggests the presence of one or more tumor suppressor genes within this region. Previously, we reported on the construction of two distinct cosmid contigs and our identification of several new genes within 3p21.1. In our search for tumor suppressor genes from this region, we have cloned a gene that we have called DRR 1 (downregulated in renal cell carcinoma). The gene was first mapped to 3p21.1 by fluorescence in situ hybridization analysis. Further analysis of yeast artificial chromosome clones in 3p14.2–p21.1 refined its localization. DRR 1 spans about 10 Kb of genomic DNA with a 3.5‐Kb mature transcript. The putative protein encoded by this gene is 144 amino acids and includes a nuclear localization signal and a coiled domain. The gene showed loss of expression in eight of eight renal cell carcinoma cell lines, one of seven ovarian cancer cell lines, one of one cervical cancer cell line, one of one gastric cancer cell line, and one of one non–small‐cell lung cancer cell line. Southern blot analysis did not show any altered bands, indicating that gross structural changes or deletions did not cause the loss of expression. This gene was also found to have reduced expression in 23 of 34 paired primary renal cell carcinomas. Mutational analysis detected three polymorphic sites within the gene, but no point mutations were identified in the 34 primary tumors. However, we did detect base substitutions in 4 of 12 cell lines that had undetectable expression of the gene. We also transfected the gene into DRR 1–negative cell lines and observed clear growth retardation. Our results suggest that loss of expression of the DRR 1 gene may play an important role in the development of renal cell carcinoma and possibly other tumors. Genes Chromosomes Cancer 27:1–10, 2000. © 2000 Wiley‐Liss, Inc.

[1]  C. Morelli,et al.  Transfer of human chromosome 3 to an ovarian carcinoma cell line identifies three regions on 3p involved in ovarian cancer. , 1994, Oncogene.

[2]  J. Minna,et al.  Human aminoacylase-1. Cloning, sequence, and expression analysis of a chromosome 3p21 gene inactivated in small cell lung cancer. , 1993, The Journal of biological chemistry.

[3]  H. Drabkin,et al.  Identification of two cosmids derived from within chromosomal band 3p21.1 that contain clusters of rare restriction sites and evolutionarily conserved sequences. , 1989, American journal of human genetics.

[4]  Haojie Huang,et al.  Fish mapping of YAC clones at human chromosomal band 7q31.2: Identification of YACS spanning FRA7G within the common region of LOH in breast and prostate cancer , 1998, Genes, chromosomes & cancer.

[5]  C. Croce,et al.  The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.

[6]  A. Kamat,et al.  Isolation of two contigs of overlapping cosmids derived from human chromosomal band 3p21.1 and identification of 5 new 3p21.1 genes , 1994, Somatic cell and molecular genetics.

[7]  W. Lee,et al.  A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC). , 1990, Oncogene.

[8]  R. Siebert,et al.  Characterization and chromosomal assignment of yeast artificial chromosomes containing human 3p13-p21-specific sequence tagged sites. , 1995, Cancer genetics and cytogenetics.

[9]  S. Naylor,et al.  Definition of a tumor suppressor locus within human chromosome 3p21-p22. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  W. Franklin,et al.  Mutational inactivation of aminoacylase‐1 in a small cell lung cancer cell line , 1998, Genes, chromosomes & cancer.

[11]  C. Croce,et al.  The role of deletions at the FRA3B/FHIT locus in carcinogenesis. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[12]  C. Croce,et al.  Structure and expression of the human FHIT gene in normal and tumor cells. , 1997, Cancer research.

[13]  S N Thibodeau,et al.  Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. , 1998, Nucleic acids research.

[14]  S. Jacobs,et al.  Hereditary renal-cell carcinoma associated with a chromosomal translocation. , 1979, The New England journal of medicine.

[15]  M. Hendrix,et al.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. , 1994, Science.

[16]  S. Naylor,et al.  Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. , 1997, Advances in cancer research.

[17]  David I. Smith,et al.  Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact , 1998, Oncogene.

[18]  D. Grignon,et al.  Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neck. , 1996, Cancer research.

[19]  D. Sidransky,et al.  Normal polymorphism in the incomplete trinucleotide repeat of the arginine-rich protein gene. , 1997, Cancer research.

[20]  S. Knuutila,et al.  Cloning and characterization of the human t(3;6)(p14;p11) translocation breakpoint associated with hematologic malignancies. , 1993, Cancer genetics and cytogenetics.

[21]  M. Oshimura,et al.  Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell‐mediated chromosome transfer , 1993, Molecular carcinogenesis.

[22]  J. Minna,et al.  A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity. , 1993, Oncogene.

[23]  P. Deloukas,et al.  A Gene Map of the Human Genome , 1996, Science.